Heidelberg Pharma AG Company Profile, Contacts & Intelligence

Heidelberg Pharma AG Overview

Heidelberg Pharma is a biopharmaceutical company working on a new treatment approach in oncology and developing novel drugs based on its ADC technologies for the targeted and highly effective treatment of cancer. ADCs are antibody-drug conjugates that combine the specificity of antibodies with the efficacy of toxins to fight cancer. Selected antibodies are loaded with cytotoxic compounds, the so-called payloads, that are transported into diseased cells. Inside the cells, the toxins then unleash their effect and kill the diseased cells. Heidelberg Pharma uses several compounds and has built up an ADC toolbox that overcomes tumor resistance via numerous pathways and addresses different types of cancer using various antibodies. The goal is to develop targeted and highly effective ADCs for the treatment of a variety of malignant hematologic and solid tumors. The company is listed on the Frankfurt Stock Exchange (FSE: HPHA). More information is available at www.heidelberg-pharma.com.

Headquarters

Ladenburg, Baden-württemberg, De

Website

www.heidelberg-pharma.com

Industry

Biotechnology Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Heidelberg Pharma AG Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Heidelberg Pharma AG People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Heidelberg Pharma AG Workforce Composition

Seniority breakdown across 4 visible profiles.

Compare Similar Companies to Heidelberg Pharma AG

Explore companies in related markets and compare their industry and employee estimates.